bindarit has been researched along with indazoles in 51 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (11.76) | 18.2507 |
2000's | 10 (19.61) | 29.6817 |
2010's | 25 (49.02) | 24.3611 |
2020's | 10 (19.61) | 2.80 |
Authors | Studies |
---|---|
Cheng, CY; Cioli, V; Guglielmotti, A; Luparini, MR; Saso, L; Silvestrini, B; Zwain, I | 1 |
Catanese, B; Ciarniello, MG; Cioli, V; Durando, L; Fava, L; Guglielmotti, A; Luparini, MR; Martinelli, B; Silvestrini, B | 1 |
Cheng, CY; Guglielmotti, A; Saso, L; Silvestrini, B; Zwain, I | 1 |
Benedetti, G; Bertani, T; Corna, D; Donadelli, R; Guglielmotti, A; Morigi, M; Pinza, M; Remuzzi, G; Zoja, C | 1 |
Braghiroli, L; Casini, ML; Grippa, E; Mattei, E; Mazzanti, G; Panzironi, C; Saso, L; Silvestrini, B; Valentini, G | 1 |
Bernasconi, S; Coletta, I; Fioretti, F; Guglielmotti, A; Mantovani, A; Milanese, C; Pinza, M; Polentarutti, N; Romano, M; Sironi, M; Sozzani, S; Vecchi, A; Vigini, C | 1 |
Appel, G; Radhakrishnan, J; Valeri, A; Zimmerman, R | 1 |
Aquilini, L; Coletta, I; D'Onofrio, E; Guglielmotti, A; Milanese, C; Pinza, M | 1 |
Bhatia, M; Chevali, L; Guglielmotti, A; Ramnath, RD | 1 |
Bravo, AI; Gazzaniga, S; Guglielmotti, A; Mantovani, A; Maschi, F; Mordoh, J; van Rooijen, N; Vecchi, A; Wainstok, R | 1 |
Bhatia, M; Guglielmotti, A; Ng, SW; Ramnath, RD | 1 |
Biondi, G; Fabbri, M; Guglielmotti, A; Locati, M; Mangano, G; Mantovani, A; Mirolo, M; Sironi, M; Vecchi, A | 1 |
Basta, F; Bhatia, M; Bovi, G; de Joannon, AC; Guglielmotti, A; Landolfi, C; Ramnath, RD | 1 |
Biondi, G; Grassia, G; Guglielmotti, A; Ialenti, A; Maddaluno, M; Maffia, P; Mangano, G | 1 |
Apicella, C; Guglielmotti, A; Mahalingam, S; Mangano, G; Rolph, MS; Rulli, NE; Suhrbier, A; Zaid, A | 1 |
Chade, AR; Daghini, E; Guglielmotti, A; Krier, JD; Lavi, R; Lerman, A; Lerman, LO; Zhu, XY | 1 |
Chen, JP; Ding, XL; Qiang, H; Wei, Q; Zhang, H; Zhang, HF; Zhou, GX; Zhu, XJ | 1 |
Baker, AH; Biondi, G; Colombo, A; Di Lauro, MV; Gordon, P; Grassia, G; Guglielmotti, A; Ialenti, A; Kennedy, S; Maddaluno, M; Maffia, P | 1 |
Biondi, G; Ble, A; Bombardieri, S; Di Loreto, G; Guglielmotti, A; Mosca, M; Remuzzi, G; Ruggenenti, P | 1 |
Anantapreecha, S; Guglielmotti, A; Mahalingam, S; Rolph, MS; Rulli, NE; Srikiatkhachorn, A | 1 |
Biondi, G; Guglielmotti, A; Mora, E; Sassone-Corsi, P | 1 |
Saccani, S | 1 |
Biondi, G; De Martino, D; Di Dato, V; Garrone, B; Guglielmotti, A; Liguori, L; Mangano, G; Marino, N; Navas, L; Spano, D; Vastolo, V; Zollo, M | 1 |
André, S; Bleich, D; Gabius, HJ; Huet, G; Kaltner, H; Kopitz, J; Ledeen, RW; Wu, G | 1 |
Cone, R; Ge, S; Guglielmotti, A; Keating, C; Pachter, JS; Paul, D; Shrestha, B | 1 |
Guglielmotti, A; Mangano, G; Musilli, C; Paccosi, S; Parenti, A | 1 |
Cicala, C; De Filippis, D; Di Lauro, MV; Grassia, G; Guglielmotti, A; Ialenti, A; Iuvone, T; Maddaluno, M; Maffia, P; Maione, F; Mascolo, N; Parisi, A | 1 |
Calissano, P; Ciotti, M; Di Matteo, A; Florenzano, F; Guglielmotti, A; Mercanti, D; Pachter, J; Passeri, PP; Possenti, R; Severini, C; Zona, C | 1 |
Davis, JM; Guglielmotti, A; McClellan, JL; Murphy, EA; Steiner, JL | 1 |
Chen, W; Foo, SS; Forwood, MR; Herrero, LJ; Hueston, L; Lulla, A; Mahalingam, S; Merits, A; Sims, NA; Taylor, A; Walsh, NC | 1 |
Buelli, S; Corna, D; Guglielmotti, A; Locatelli, M; Morigi, M; Perico, N; Pezzotta, A; Remuzzi, A; Remuzzi, G; Rottoli, D; Zanchi, C; Zoja, C | 1 |
Jiang, C; Li, J; Lian, M; Ma, C; Shen, T; Shi, J; Wang, N; Wei, L; Yu, X; Zhang, C; Zhao, X; Zhu, D | 1 |
Basavarajaiah, S; Calabresi, M; Colombo, A; Guglielmotti, A; Lettieri, C; Limbruno, U; Picchi, A; Pierucci, D; Prati, F; Sciahbasi, A; Valgimigli, M | 1 |
Allegra, M; Bozzi, Y; Caleo, M; Cerri, C; Genovesi, S; Guglielmotti, A; Perry, VH; Pistillo, F; Püntener, U | 1 |
Di Gennaro, P; Giachi, M; Guglielmotti, A; Paccosi, S; Parenti, A | 1 |
Chu, CR; Giori, NJ; Goodman, SB; Lepus, CM; Lingampalli, N; Oliviero, F; Punzi, L; Raghu, H; Robinson, WH; Sokolove, JB; Wang, Q; Wong, HH | 1 |
Furugen, A; Futagi, Y; Iseki, K; Kobayashi, M; Narumi, K | 1 |
Gao, C; Gao, H; Liu, S; Liu, W; Xing, D | 1 |
Frank, JA; Luo, J; Wang, H; Xu, M; Zhang, K | 1 |
Altschuler, F; Aranda, ML; Chianelli, MS; Dieguez, HH; Dorfman, D; González Fleitas, MF; Guerrieri, D; Keller Sarmiento, MI; Piñero, G; Rosenstein, RE; Sande, PH | 1 |
Alisi, MA; Angelucci, C; Assfalg, M; Caltagirone, C; Coletta, I; Dainese, E; Dufrusine, B; Maccarrone, M; Oddi, S; Polenzani, L; Sabatucci, A; Scipioni, L; Tortolani, D; Totaro, A | 1 |
Huang, X; Li, H; Li, L; Lou, W; Zhu, Y | 1 |
Li, X; Liu, F; Liu, J; Peng, C; Tang, Y; Xiang, T; Yin, L; Yuan, Y; Zhou, X | 1 |
Chen, J; Guan, M; Huang, X; Kuang, S; Lin, Z; Qin, W; Shen, Z; Xu, HHK; Zhang, M | 1 |
Lai, Q; Li, W; Lou, J; Peng, C; Teng, Z; Xu, C; Yin, L; Zhang, C; Zhou, X | 1 |
Chi, ZF; Kang, AL; Liu, YX; Nie, LH; Niu, CY; Wang, P; Wang, Q; Wei, D; Zhang, H; Zhang, LM; Zhao, M; Zhao, ZA; Zhao, ZG | 1 |
Furugen, A; Iseki, K; Kobayashi, M; Nadai, T; Narumi, K; Saito, Y | 1 |
Berta, T; Brown, FN; Campbell, K; Goto, J; Iwasawa, E; Kahn, F; Ladle, DR; Lee, SH; Mangano, FT; Shula, C | 1 |
Bai, XC; Hu, HL; Lai, PL; Wang, XJ; Yang, JC; Yuan, SG; Zhou, RP | 1 |
Cai, C; Kilari, S; Misra, S; Singh, AK | 1 |
Chao, W; Gu, CJ; Hadas, E; Kelschenbach, J; Kim, BH; Potash, MJ; Volsky, DJ | 1 |
2 review(s) available for bindarit and indazoles
Article | Year |
---|---|
Advances in the treatment of lupus nephritis.
Topics: Abatacept; Antigens, CD; Antigens, Differentiation; CTLA-4 Antigen; Cyclosporins; Humans; Immunoconjugates; Immunoglobulins, Intravenous; Immunosuppressive Agents; Indazoles; Linseed Oil; Lupus Nephritis; Morbidity; Mycophenolic Acid; Oligonucleotides; Plasmapheresis; Propionates; Treatment Outcome | 2001 |
Beyond glycoproteins as galectin counterreceptors: tumor-effector T cell growth control via ganglioside GM1 [corrected].
Topics: Animals; Anoikis; Cell Communication; G(M1) Ganglioside; Galectins; Glycoproteins; Humans; Indazoles; Mice; Models, Immunological; Morpholines; Neoplasms; Propionates; Signal Transduction; T-Lymphocytes | 2012 |
2 trial(s) available for bindarit and indazoles
Article | Year |
---|---|
Antiproteinuric effect of chemokine C-C motif ligand 2 inhibition in subjects with acute proliferative lupus nephritis.
Topics: Acute Disease; Adult; Chemokine CCL2; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Indazoles; Kidney Diseases; Lupus Nephritis; Male; Middle Aged; Placebos; Propionates; Prospective Studies; Proteinuria; Remission Induction | 2011 |
A double-blind randomised study to evaluate the efficacy and safety of bindarit in preventing coronary stent restenosis.
Topics: Adolescent; Adult; Aged; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Double-Blind Method; Drug-Eluting Stents; Female; Humans; Indazoles; Male; Middle Aged; Percutaneous Coronary Intervention; Propionates; Treatment Outcome; Young Adult | 2016 |
47 other study(ies) available for bindarit and indazoles
Article | Year |
---|---|
Abnormal glycosylation of hemopexin in arthritic rats can be blocked by bindarit.
Topics: Acute-Phase Reaction; Amino Acid Sequence; Animals; Arthritis, Experimental; Blood Proteins; Chromatography, High Pressure Liquid; Concanavalin A; Electrophoresis, Polyacrylamide Gel; Endopeptidases; Freund's Adjuvant; Glycosylation; Hemopexin; Immunoblotting; Indazoles; Molecular Sequence Data; Propionates; Rats; Rats, Sprague-Dawley; Staining and Labeling | 1992 |
A new protein antidenaturant agent, bindarit, reduces secondary phase of adjuvant arthritis in rats.
Topics: Animals; Arthritis, Experimental; Blood Sedimentation; Cattle; Cytokines; Female; Hot Temperature; Indazoles; Indomethacin; Lipoxygenase; Male; Mice; Propionates; Prostaglandin-Endoperoxide Synthases; Protein Denaturation; Rats; Serum Albumin | 1992 |
Chronic inflammatory response in the rat can be blocked by bindarit.
Topics: Acute-Phase Proteins; alpha-Macroglobulins; Animals; Arthritis, Experimental; Clusterin; Concanavalin A; Electrophoresis, Polyacrylamide Gel; Glycoproteins; Indazoles; Indomethacin; Male; Molecular Chaperones; Propionates; Proteins; Radioimmunoassay; Rats; Saposins; Serum Albumin | 1993 |
Bindarit retards renal disease and prolongs survival in murine lupus autoimmune disease.
Topics: Animals; Antibodies, Antinuclear; Blood Urea Nitrogen; Chemokine CCL2; Female; Humans; Indazoles; Inflammation Mediators; Kidney; Lupus Nephritis; Methylprednisolone; Mice; Mice, Inbred NZB; Propionates; Proteinuria; Rats | 1998 |
Inhibition of protein denaturation by fatty acids, bile salts and other natural substances: a new hypothesis for the mechanism of action of fish oil in rheumatic diseases.
Topics: Administration, Oral; Amino Acids; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bile Acids and Salts; Blood Proteins; Cattle; Charcoal; Chemical Fractionation; Dialysis; Fatty Acids; Fetal Blood; Fish Oils; Hot Temperature; Humans; Indazoles; Propionates; Protein Denaturation; Rats; Rats, Wistar; Rheumatic Diseases; Salts; Serum Albumin; Sodium Chloride; Tromethamine | 1999 |
A small synthetic molecule capable of preferentially inhibiting the production of the CC chemokine monocyte chemotactic protein-1.
Topics: Animals; Cell Line; Chemokine CCL2; Chemokines; Cytokines; Female; Humans; Indazoles; Mice; Monocytes; Propionates | 1999 |
Amelioration of rat adjuvant arthritis by therapeutic treatment with bindarit, an inhibitor of MCP-1 and TNF-alpha production.
Topics: Animals; Arthritis, Experimental; Cell Line; Chemokine CCL2; Cytokines; Hindlimb; Humans; Immunity; Indazoles; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Osteoblasts; Ovalbumin; Propionates; Radiography; Rats; Tumor Necrosis Factor-alpha | 2002 |
Treatment with bindarit, a blocker of MCP-1 synthesis, protects mice against acute pancreatitis.
Topics: Acute Disease; Animals; Ceruletide; Chemokine CCL2; Disease Models, Animal; Indazoles; Inflammation; Mice; Necrosis; Pancreas; Pancreatitis; Propionates | 2005 |
Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft.
Topics: Animals; Cell Line, Tumor; Chemokine CCL2; Clodronic Acid; Humans; Indazoles; Liposomes; Macrophages; Male; Melanoma, Experimental; Mice; Neoplasm Transplantation; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1; Propionates; Transplantation, Heterologous | 2007 |
Role of MCP-1 in endotoxemia and sepsis.
Topics: Animals; Calmodulin; Chemokine CCL2; Endotoxemia; Indazoles; Lipopolysaccharides; Liver; Lung; Mice; Peritonitis; Peroxidase; Propionates; Sepsis | 2008 |
Impact of the anti-inflammatory agent bindarit on the chemokinome: selective inhibition of the monocyte chemotactic proteins.
Topics: Anti-Inflammatory Agents; Cells, Cultured; Chemokine CCL2; Chemokine CCL7; Chemokine CCL8; Endothelial Cells; Enzyme-Linked Immunosorbent Assay; Humans; Indazoles; Monocyte Chemoattractant Proteins; Monocytes; Propionates; Reverse Transcriptase Polymerase Chain Reaction | 2008 |
Treatment with bindarit, an inhibitor of MCP-1 synthesis, protects mice against trinitrobenzene sulfonic acid-induced colitis.
Topics: Animals; Cells, Cultured; Chemokine CCL2; Colitis; Disease Progression; Epithelial Cells; Female; Humans; Indazoles; Interferon-gamma; Mice; Mice, Inbred BALB C; Propionates; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha | 2008 |
The anti-inflammatory agent bindarit inhibits neointima formation in both rats and hyperlipidaemic mice.
Topics: Animals; Anti-Inflammatory Agents; Apolipoproteins E; Carotid Arteries; Carotid Artery Injuries; Cell Movement; Cell Proliferation; Cells, Cultured; Chemokine CCL2; Disease Models, Animal; Female; Hyperlipidemias; Indazoles; Male; Mice; Mice, Knockout; Muscle, Smooth, Vascular; Propionates; Rats; Rats, Wistar | 2009 |
Amelioration of alphavirus-induced arthritis and myositis in a mouse model by treatment with bindarit, an inhibitor of monocyte chemotactic proteins.
Topics: Alphavirus; Alphavirus Infections; Animals; Antirheumatic Agents; Arthritis, Experimental; Cell Line; Disease Models, Animal; Down-Regulation; Humans; Indazoles; Macrophages; Mice; Mice, Inbred C57BL; Monocyte Chemoattractant Proteins; Muscle, Skeletal; Myositis; Propionates; RNA, Messenger | 2009 |
The chemokine monocyte chemoattractant protein-1 contributes to renal dysfunction in swine renovascular hypertension.
Topics: Animals; Chemokine CCL2; Disease Models, Animal; Fibrosis; Hypertension, Renovascular; Indazoles; Kidney Tubules; NADPH Oxidases; Nephritis; NF-kappa B; Propionates; Receptors, CCR2; Renal Artery Obstruction; Renal Circulation; Sus scrofa; Up-Regulation; Urothelium | 2009 |
Protective effects of MCP-1 inhibitor on a rat model of severe acute pancreatitis.
Topics: Acute Disease; Amylases; Animals; Chemokine CCL2; Immunohistochemistry; Indazoles; Male; Pancreas; Pancreatitis; Propionates; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2010 |
Inhibition of in-stent stenosis by oral administration of bindarit in porcine coronary arteries.
Topics: Administration, Oral; Animals; Cell Proliferation; Coronary Stenosis; Coronary Vessels; Indazoles; Male; Models, Animal; Monocyte Chemoattractant Proteins; Muscle, Smooth, Vascular; Neointima; Propionates; Stents; Swine; Treatment Outcome | 2011 |
Protection from arthritis and myositis in a mouse model of acute chikungunya virus disease by bindarit, an inhibitor of monocyte chemotactic protein-1 synthesis.
Topics: Alphavirus Infections; Animals; Arthritis, Infectious; Chemokine CCL2; Chikungunya Fever; Chikungunya virus; Humans; Indazoles; Interferon-gamma; Mice; Mice, Inbred C57BL; Models, Animal; Myositis; Propionates; Tumor Necrosis Factor-alpha; Viral Load | 2011 |
Bindarit: an anti-inflammatory small molecule that modulates the NFκB pathway.
Topics: Animals; Anti-Inflammatory Agents; Base Sequence; Cells, Cultured; Chemokine CCL2; Down-Regulation; I-kappa B Proteins; Indazoles; Interleukin-12 Subunit p40; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Molecular Sequence Data; NF-kappa B; Phosphorylation; Promoter Regions, Genetic; Propionates; Signal Transduction; Transcription Factor RelA | 2012 |
All p65-containing dimers are not equal.
Topics: Animals; Anti-Inflammatory Agents; Indazoles; NF-kappa B; Propionates | 2012 |
Targeting monocyte chemotactic protein-1 synthesis with bindarit induces tumor regression in prostate and breast cancer animal models.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chemokine CCL2; Female; Humans; Indazoles; Macrophages; Male; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Neoplasm Transplantation; NF-kappa B; Propionates; Prostatic Neoplasms; Signal Transduction | 2012 |
The CCL2 synthesis inhibitor bindarit targets cells of the neurovascular unit, and suppresses experimental autoimmune encephalomyelitis.
Topics: Amino Acid Sequence; Animals; Cells, Cultured; Chemokine CCL2; Drug Delivery Systems; Encephalomyelitis, Autoimmune, Experimental; Female; Indazoles; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Propionates; Spinal Cord | 2012 |
The monocyte chemotactic protein synthesis inhibitor bindarit prevents mesangial cell proliferation and extracellular matrix remodeling.
Topics: Blotting, Western; Cell Culture Techniques; Cell Line; Cell Proliferation; Chemokine CCL2; Extracellular Matrix; Humans; Indazoles; Mesangial Cells; Propionates; Reverse Transcriptase Polymerase Chain Reaction | 2012 |
Bindarit inhibits human coronary artery smooth muscle cell proliferation, migration and phenotypic switching.
Topics: Actins; Animals; Calcium-Binding Proteins; Calponins; Cell Differentiation; Cell Movement; Cell Proliferation; Coronary Vessels; Gene Expression; Humans; Indazoles; Microfilament Proteins; Monocyte Chemoattractant Proteins; Myocytes, Smooth Muscle; Myosin Heavy Chains; Neointima; Propionates; Rats | 2012 |
Bindarit, inhibitor of CCL2 synthesis, protects neurons against amyloid-β-induced toxicity.
Topics: Adenosine Triphosphate; Amyloid beta-Peptides; Animals; Cell Survival; Cerebral Cortex; Chemokine CCL2; Dose-Response Relationship, Drug; Embryo, Mammalian; Enzyme Inhibitors; Female; Gene Expression Regulation; Indazoles; Neuroglia; Neurons; Neuroprotective Agents; Peptide Fragments; Pregnancy; Propionates; Rats; Rats, Wistar | 2014 |
Effects of the MCP-1 synthesis inhibitor bindarit on tumorigenesis and inflammatory markers in the C3(1)/SV40Tag mouse model of breast cancer.
Topics: Animals; Antigens, Polyomavirus Transforming; Biomarkers; Body Weight; Carcinogenesis; Chemokine CCL2; Disease Models, Animal; Feeding Behavior; Female; Gene Expression Regulation; Indazoles; Inflammation Mediators; Interleukin-6; Macrophages; Mammary Glands, Animal; Mammary Neoplasms, Animal; Mice; Mice, Transgenic; Organ Size; Propionates; RNA, Messenger; Spleen; Tumor Burden; Tumor Necrosis Factor-alpha | 2014 |
Bindarit, an inhibitor of monocyte chemotactic protein synthesis, protects against bone loss induced by chikungunya virus infection.
Topics: Adult; Aged; Animals; Bone Density Conservation Agents; Bone Resorption; Chemokine CCL2; Chikungunya Fever; Disease Models, Animal; Female; Humans; Indazoles; Male; Mice, Inbred C57BL; Middle Aged; Propionates | 2015 |
Effects of MCP-1 inhibition by bindarit therapy in a rat model of polycystic kidney disease.
Topics: Animals; Chemokine CCL2; Disease Models, Animal; In Vitro Techniques; Indazoles; Macrophages; Male; Monocytes; Podocytes; Polycystic Kidney, Autosomal Dominant; Propionates; Proteinuria; Rats; Rats, Mutant Strains; Rats, Sprague-Dawley; RNA, Messenger | 2015 |
15-Lipoxygenase and 15-hydroxyeicosatetraenoic acid regulate intravascular thrombosis in pulmonary hypertension.
Topics: Animals; Arachidonate 15-Lipoxygenase; Blood Platelets; Cells, Cultured; Chemokine CCL2; Cytokines; Humans; Hydroxyeicosatetraenoic Acids; Hypertension, Pulmonary; Hypoxia; Indazoles; Lipoxygenase Inhibitors; Male; Masoprocol; Platelet Activation; Propionates; Pulmonary Artery; Random Allocation; Rats; Rats, Wistar; RNA Interference; RNA, Small Interfering; Signal Transduction; Thrombosis; Vascular Resistance | 2015 |
The Chemokine CCL2 Mediates the Seizure-enhancing Effects of Systemic Inflammation.
Topics: Animals; Antibodies; Benzoxazines; Chemokine CCL2; Disease Models, Animal; Electroencephalography; Epilepsy, Temporal Lobe; Excitatory Amino Acid Agonists; Hippocampus; Indazoles; Inflammation; Kainic Acid; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Piperidines; Propionates; Receptors, CCR2; RNA, Messenger; Signal Transduction; Up-Regulation | 2016 |
The chemokine (C-C motif) ligand protein synthesis inhibitor bindarit prevents cytoskeletal rearrangement and contraction of human mesangial cells.
Topics: Actins; Angiotensin II; Anti-Inflammatory Agents; Cells, Cultured; Chemokines; Cytoskeleton; Endothelin-1; Glomerular Mesangium; Humans; Indazoles; Ligands; Mesangial Cells; Propionates; Protein Synthesis Inhibitors; Transforming Growth Factor beta; Up-Regulation | 2016 |
CCL2/CCR2, but not CCL5/CCR5, mediates monocyte recruitment, inflammation and cartilage destruction in osteoarthritis.
Topics: Animals; Cartilage, Articular; Chemokine CCL2; Chemokine CCL5; Chemokines; Chemotaxis; Fibroblasts; Gene Expression; Humans; Indazoles; Leukocyte Count; Macrophages; Male; Mice, Inbred C57BL; Mice, Knockout; Monocytes; Osteoarthritis; Propionates; Receptors, CCR2; Receptors, CCR5; RNA, Messenger; Signal Transduction; Synovial Fluid | 2017 |
Identification of a selective inhibitor of human monocarboxylate transporter 4.
Topics: Animals; Biological Transport; Cells, Cultured; Drug Discovery; Female; Fibric Acids; Humans; Indazoles; Isobutyrates; Lactic Acid; Monocarboxylic Acid Transporters; Muscle Proteins; Oocytes; Propionates; Protein Isoforms; Xenopus laevis | 2018 |
Bindarit Attenuates Pain and Cancer-Related Inflammation by Influencing Myeloid Cells in a Model of Bone Cancer.
Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Carcinogenesis; Cell Line, Tumor; Chemokine CCL2; Disease Models, Animal; Humans; I-kappa B Kinase; Indazoles; Inflammation; Male; Mice; Mice, Nude; Myeloid Cells; Neoplasms, Experimental; Propionates; Signal Transduction; Tumor Burden | 2018 |
Role of MCP-1 and CCR2 in ethanol-induced neuroinflammation and neurodegeneration in the developing brain.
Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents; Benzoxazines; Brain; Caspase 3; Cells, Cultured; Central Nervous System Depressants; Chemokine CCL2; Disease Models, Animal; Encephalitis; Ethanol; Gene Expression Regulation, Developmental; Indazoles; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microglia; Neurodegenerative Diseases; Propionates; Receptors, CCR2; Signal Transduction; Spiro Compounds | 2018 |
Critical Role of Monocyte Recruitment in Optic Nerve Damage Induced by Experimental Optic Neuritis.
Topics: Animals; Blood-Brain Barrier; Chemokine CCL2; Indazoles; Lipopolysaccharides; Male; Monocytes; Optic Nerve; Optic Neuritis; Permeability; Propionates; Rats, Wistar; Recombinant Proteins; Tissue Plasminogen Activator | 2019 |
The anti-inflammatory agent bindarit acts as a modulator of fatty acid-binding protein 4 in human monocytic cells.
Topics: Active Transport, Cell Nucleus; Anti-Inflammatory Agents; Cell Line; Cell Nucleus; Chemokine CCL2; Fatty Acid-Binding Proteins; Humans; Immunologic Factors; Indazoles; Interleukin-8; Lipopolysaccharides; Models, Biological; Monocytes; p38 Mitogen-Activated Protein Kinases; PPAR gamma; Propionates; Protein Binding; Up-Regulation | 2019 |
Upregulated C-C Motif Chemokine Ligand 2 Promotes Ischemic Stroke via Chemokine Signaling Pathway.
Topics: Animals; Brain; Chemokine CCL2; Disease Models, Animal; Humans; Indazoles; Infarction, Middle Cerebral Artery; Locomotion; Male; Neuroprotective Agents; Propionates; Protein Interaction Maps; Rats, Sprague-Dawley; Signal Transduction; Transcriptome; Up-Regulation | 2020 |
Biomimetic oral targeted delivery of bindarit for immunotherapy of atherosclerosis.
Topics: Administration, Oral; Animals; Biocompatible Materials; Biomimetics; Carbocyanines; Cells, Cultured; Chemokine CCL2; Dose-Response Relationship, Drug; Drug Delivery Systems; Immunotherapy; Indazoles; Male; Mice; Mice, Knockout; Plaque, Atherosclerotic; Propionates; RAW 264.7 Cells | 2020 |
Inhibition of CCL2 by bindarit alleviates diabetes-associated periodontitis by suppressing inflammatory monocyte infiltration and altering macrophage properties.
Topics: Chemokine CCL2; Diabetes Mellitus; Humans; Indazoles; Macrophages; Monocytes; Periodontitis; Propionates | 2021 |
Prevention of Obesity Related Diseases through Laminarin-induced targeted delivery of Bindarit.
Topics: Adipose Tissue; Animals; Atherosclerosis; Computer Simulation; Diet, High-Fat; Fatty Liver; Glucans; Humans; Indazoles; Inflammation; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Monocytes; Nanoparticles; Obesity; Plaque, Atherosclerotic; Propionates | 2020 |
Transcriptome Analysis Revealed Inflammation Is Involved in the Impairment of Human Umbilical Vein Endothelial Cells Induced by Post-hemorrhagic Shock Mesenteric Lymph.
Topics: Animals; Anti-Inflammatory Agents; Cells, Cultured; Disease Models, Animal; Gene Expression Profiling; Gene Regulatory Networks; Human Umbilical Vein Endothelial Cells; Humans; Indazoles; Inflammation; Lymph; Lymphatic System; Male; Mesentery; Propionates; Rats, Wistar; Shock, Hemorrhagic; Signal Transduction; Transcriptome | 2020 |
Pharmacological Inhibition of MCT4 Reduces 4-Hydroxytamoxifen Sensitivity by Increasing HIF-1α Protein Expression in ER-Positive MCF-7 Breast Cancer Cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Indazoles; MCF-7 Cells; Monocarboxylic Acid Transporters; Muscle Proteins; Propionates; Receptors, Estrogen; Tamoxifen | 2021 |
The Anti-Inflammatory Agent Bindarit Attenuates the Impairment of Neural Development through Suppression of Microglial Activation in a Neonatal Hydrocephalus Mouse Model.
Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents; Disease Models, Animal; Female; Humans; Hydrocephalus; Indazoles; Mice; Microglia; Pregnancy; Propionates | 2022 |
Bindarit Reduces Bone Loss in Ovariectomized Mice by Inhibiting CCL2 and CCL7 Expression via the NF-κB Signaling Pathway.
Topics: Animals; Bone Diseases, Metabolic; Bone Resorption; Cell Differentiation; Chemokine CCL2; Chemokine CCL7; Cytokines; Female; Humans; I-kappa B Kinase; Indazoles; Mice; NF-kappa B; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Ovariectomy; Propionates; RNA, Messenger; Signal Transduction; X-Ray Microtomography | 2022 |
Bindarit encapsulated nanoparticles prevent venous neointimal hyperplasia and restenosis in a murine angioplasty model.
Topics: Angioplasty; Animals; Arteriovenous Fistula; Chromatography, Liquid; Constriction, Pathologic; Disease Models, Animal; Hyperplasia; Indazoles; Mice; Nanoparticles; Neointima; Propionates; Renal Dialysis; Tandem Mass Spectrometry | 2022 |
CCL2 is required for initiation but not persistence of HIV infection mediated neurocognitive disease in mice.
Topics: AIDS Dementia Complex; Animals; Chemokine CCL2; Cognition; Disease Models, Animal; HIV Infections; Indazoles; Mice; Mice, Inbred C57BL; Mice, Knockout; Monocytes; Receptors, CCR2 | 2023 |